Ann: Biome Releases First Half FY2024 Results, page-9

The staff share plan was voted on at the AGM. My understanding is that the company will issue a non-recourse loan to the directors to purchase shares in the company at a fixed price of $0.14. As they purchase the shares (which are issued) the company will receive cash to offset the loan. Therefore the accounting treatment will look something like this

Company issues Shares to Directors therefore net assets will rise by that amount
Company issues a loan for the value of the shares at $0.14 which will show up as a receivable
Directors will slowly pay for the shares (I assume salary sacrifice) and the debt will go down and there will be less cash outflow

Overall, if the share price remains above $0.14 the balance sheet will improve equal to the value of the shares issued

Not an expert here but that’s how I understood it when we voted at the AGM